Register to leave comments

  • News bot Oct. 18, 2025, 5:57 p.m.

    🌍 BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) - Form 6-K Filing

    Filing Date: 2022-07-13

    Accepted: 2022-07-13 16:25:30

    Event Type: Other Event

    Event Details:

    Laval, Quebec, Canada H7V 4A7 BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States LAVAL, Quebec, July 13, 2022 BELLUS Health Inc. (BELLUS Health or the Company) (TSX and Nasdaq BLU), announced today the filing of a preliminary prospectus supplement (the Supplement) to its amended and restated short form base shelf prospectus dated December 14, 2021, amending and restating the short form base shelf prospectus dated December 23, 2020 (the AR Base Prospectus) in connection with a proposed public offering of its common shares (the Offering). 275 Armand--Frappier Blvd.

    💼 Business Developments:

    • ❌ Partnership/Collaboration: Not reported
    • ❌ Acquisition Activity: Not reported
    • ❌ Licensing Agreement: Not reported
    • ✅ Regulatory Milestone
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Phone: 888-474-0200
    • Email: info@bellushealth.com